Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.’s (HKG:6990) 27% Price Boost Is Out Of Tune With Revenues
Despite an already strong run, Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG:6990) shares have been powering on, with a gain of 27% in the last thirty days. The last month tops off a massive increase of 107% in the last year.
Since its price has surged higher, Sichuan Kelun-Biotech Biopharmaceutical may be sending very bearish signals at the moment with a price-to-sales (or “P/S”) ratio of 33.3x, since almost half of all companies in the Biotechs industry in Hong Kong have P/S ratios under 8.7x and even P/S lower than 4x are not unusual. Nonetheless, we’d need to dig a little deeper to determine if there is a rational basis for the highly elevated P/S.
We’ve found 21 US stocks that are forecast to pay a dividend…
